Pediatric restrictive cardiomyopathy associated with a mutation in β-myosin heavy chain
Most children do not have a known cause of cardiomyopathy which limits the potential for disease‐specific therapies. Of the different phenotypic presentations of cardiomyopathy, the restrictive form carries the poorest prognosis and has the lowest rate of identification of etiology. We present the f...
Saved in:
Published in | Clinical genetics Vol. 73; no. 2; pp. 165 - 170 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.02.2008
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Most children do not have a known cause of cardiomyopathy which limits the potential for disease‐specific therapies. Of the different phenotypic presentations of cardiomyopathy, the restrictive form carries the poorest prognosis and has the lowest rate of identification of etiology. We present the first description of a β‐myosin heavy chain gene mutation in an infant with restrictive cardiomyopathy requiring cardiac transplantation. As demonstrated by three‐dimensional protein structure modeling, the missense mutation is in a highly conserved amino acid at the critical binding region for the essential light chain. This case emphasizes that mutations in sarcomeric proteins, which are known to cause hypertrophic cardiomyopathy in adults, may be associated with the development of restrictive physiology in childhood. Identification of the genetic basis of pediatric cardiomyopathy has important implications for management and genetic counseling. |
---|---|
Bibliography: | istex:19D8175067327BA0F8E9610E8EBC705EB60080B9 ArticleID:CGE939 ark:/67375/WNG-NC795LK1-Z ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 0009-9163 1399-0004 |
DOI: | 10.1111/j.1399-0004.2007.00939.x |